A new pathology test using AI can accurately predict clinically significant prostate cancer disease progression following surgery, helping guide treatment decisions. The Precise MD post-op test reclassified 58% of intermediate risk patients as low risk and 42% as high risk for significant disease progression.
A specific protein called TEAD1 has been identified as a key regulator of tumor migration in glioblastoma, a devastating form of brain cancer. By deactivating this protein, researchers may be able to stop tumor cells from migrating away from the main tumor mass, increasing the success rate and overall survival time for patients.
Researchers at Mount Sinai Hospital have found a link between high doses of sildenafil citrate and irreversible damage to color vision. The study used advanced imaging technology to visualize the structural changes in the retina caused by excessive use of the drug.
Researchers found intravitreal treatments to be superior to periocular injections in reducing macular edema and improving visual acuity. The study suggests shifting towards intravitreal corticosteroid injections for treating uveitic macular edema.
Researchers at Mount Sinai discover that an antimicrobial protein in the gut can prevent graft-versus-host-disease, a common and lethal side effect of bone marrow transplants. The protein, REG3α, may lead to new treatments for inflammatory bowel disease and other GI illnesses.
A study published in JAMA Oncology found that patients treated with more-invasive surgical techniques for early-stage lung cancer were more likely to become chronic opioid users. In contrast, those who underwent minimally invasive VATS surgery were less likely to fill opioid prescriptions after surgery and in the long term.
Researchers have identified a novel gut-brain neural circuit establishing the vagus nerve as essential for regulating reward and motivation. The study reveals that stimulating the right branch of the vagus nerve can excite reward neurons in the brain, offering potential targets for therapy for eating and emotional disorders.
Researchers found that women who experienced higher levels of trauma and secreted higher levels of cortisol in late pregnancy had male infants with lower birth weights, averaging a 38-gram decrease. The study's results suggest that maternal trauma can have lasting effects on fetal development.
Researchers at Mount Sinai discovered that stromal cells in bladder cancer tumors prevent immune cells from attacking them, leading to low response rates with PD-1/PD-L1 inhibitors. The study identified genes linked to more aggressive cancers and found that tumors with these genes were less responsive to treatment.
Mount Sinai researchers discovered a novel epigenetic mechanism causing drug resistance in melanoma patients with BRAF gene mutations. A biomarker called IGFBP2 was also identified, which could benefit from combination therapies that inhibit BRAF and IGFBP2-driven pathways.
Researchers at Mount Sinai have successfully restored vision in mice by activating retinal stem cells, which could lead to treatments for patients with blinding diseases. The study found that new rod photoreceptor cells were generated and integrated into the existing retinal structure, restoring function of the visual pathway.
Scientists have identified a method to grow dendritic cells at scale in the lab, enabling more precise cancer vaccines and potentially improving organ transplant rejection outcomes. This discovery could lead to breakthroughs in cancer treatment and other immunological therapies.
A study published in The Lancet Psychiatry found that switching antipsychotic medications in patients with first-episode schizophrenia does not improve clinical outcomes. Instead, earlier treatment with clozapine, an effective antipsychotic medication, can be started earlier to potentially save time and reduce suffering.
An AI platform identified diseases in CT scans faster than human diagnosis, with a total processing and interpretation time of 1.2 seconds, significantly outperforming human triage systems.
Researchers at Mount Sinai will investigate the use of inhaled corticosteroids to treat sickle cell disease, a condition that affects 100,000 Americans and has high healthcare costs. The IMPROVE 2 study aims to improve patient outcomes and reduce ED visits.
The Icahn Institute is partnering with the National Institutes of Health to establish a center for reproducible biomedical modeling, aiming to accelerate development of predictive models for precision medicine and bioengineering. The center will provide much-needed model building resources to the research community.
A new RNA sequencing platform has been developed to match thousands of drugs with late-stage and drug-resistant multiple myeloma patients, providing a more accurate treatment approach. The platform's results showed that a majority of patients benefited from personalized treatment plans based on their cancer's RNA profile.
Researchers have discovered a novel way to enhance targeted cancer drugs by testing cocktail combinations on human cancer cell lines, fruit flies, and mice. The findings suggest that these cocktail combinations can be used with targeted therapy drugs or after failed attempts.
Researchers at Mount Sinai Hospital discovered a new gene, HIP1, linked to disease severity in rheumatoid arthritis. The study found that knocking out the gene reduced synovial fibroblast invasiveness and protected against arthritis progression.
Researchers discovered that brain microglia clearance activity in different regions goes hand in hand with natural neuronal degeneration. Microglia can mistakenly attack healthy neurons if their 'eating' behavior is turned on inappropriately, leading to cellular changes associated with neurodegenerative diseases.
Researchers at Mount Sinai have discovered two microRNA activity-based biomarkers that can predict patient outcomes and inform treatment decisions for p53-like bladder cancer. The findings hold promise for personalized treatment options, but further research is needed to translate the results into improved patient care.
Researchers have identified a new gene-activation pathway caused by lipids associated with coronary artery disease, which could help identify new directions in research and drug development. The study found that exposure to lipids activates the MTHFD2 gene in the walls of blood vessels.
Researchers identified adventitial CD90+ and mesenchymal stem cells in human arteries for the first time, providing a clear link to vascular diseases like coronary artery disease. These cells appear to play a key role in mediating vascular diseases.
A new study published in JAMA Internal Medicine finds that hospital at home (HaH) care reduces length of stay, hospital readmissions, emergency department visits, and transfers to skilled nursing facilities. HaH also improves patient experience and satisfaction rates compared to traditional inpatient care.
Research found that human herpesvirus 6A and 7 are present in Alzheimer's brains at higher levels than in those without the disease. The study identified previously unknown gene networks that could reveal novel targets for new drugs, and may help prevent or arrest the progression of the disease.
Researchers discovered a higher risk of major congenital malformations in fetuses exposed to lithium during the first trimester. The absolute risk was nearly one and one-half times higher than in unexposed babies.
A study published in Anesthesiology found that IV acetaminophen does not meaningfully decrease opioid use after surgery compared to oral acetaminophen. Researchers suggest that eliminating IV acetaminophen may result in significant cost savings for hospitals.
A Journal of Neuroscience study found that a transcription factor called FosB plays a key role in regulating aggressive behavior in mice. Increased FosB levels were linked to increased aggression intensity and dominance.
A new diagnostic test that uses a simple nasal brush to identify mild to moderate asthma has been developed by Mount Sinai researchers. The test, which uses machine learning algorithms and RNA sequencing, can differentiate asthma from other respiratory conditions and is less expensive than traditional pulmonary function testing.
Researchers developed an experimental model of HIV infection in mice that shows HIV causes learning and memory dysfunction, a common problem in half of HIV-infected people. The virus establishes latent and active reservoirs in T cells and macrophages, leading to cognitive impairment.
Research reveals that impaired neural mechanisms in six large-scale brain networks contribute to human drug addiction behaviors, affecting cognition, emotional processing, and decision-making. The study identifies consistent impairments in brain function across these networks, which can inform the development of targeted treatment inte...
Researchers identified epigenetic mutations as significant contributors to neurodevelopmental disorders and congenital anomalies. The discovery could lead to advanced diagnostic tools, say researchers from the Icahn School of Medicine at Mount Sinai.
The i3 Asset Accelerator is a new fund that fast-tracks select research discoveries to reach patients sooner. The accelerator has selected its first two projects, focused on cancer treatment and influenza B viral infections, with the goal of advancing commercially relevant solutions globally.
A study published in JAMA Internal Medicine found that palliative care is associated with shorter hospital stays and lower costs, particularly for patients with complex conditions. The study showed a cost savings of $4,251 per patient with cancer and $2,105 for those with non-cancer diagnoses.
A common genetics study method called Mendelian randomization has been found to be distorted by a phenomenon called horizontal pleiotropy in nearly 50% of its studies. This distortion can lead to false positive causal relationships and affects the accuracy of drug discovery and disease management.
A recent Mount Sinai study reveals individuals with IBD have a 28% higher risk of developing Parkinson's disease; treated patients show significant reduction in risk after anti-TNFα therapy. The study suggests exploring anti-TNFα to prevent Parkinson's disease in high-risk individuals.
The Mount Sinai team will develop software tools for efficient and interactive analysis of large amounts of single-cell data, accelerating progress toward curing all diseases by the end of the century. The CZI grant aims to provide a platform for scientists to analyze massive data sets interactively and quickly.
The study, funded by the National Eye Institute, tested oral omega-3 supplementation on patients with dry eye disease. Despite finding some improvement in symptoms and signs, researchers concluded that omega-3 supplements did not show a beneficial effect relative to placebo.
Researchers found that simultaneous chemotherapy and immunotherapy is safe and patients with certain genetic mutations may respond particularly well. The combination approach was shown to boost immune cells in the blood, allaying previous concerns about chemotherapy's impact on immunotherapy.
A US task force identified five global best practices for improving community health, including local anchor institutions, shared goals, and simple protocols. These findings hold great potential to improve the health of struggling communities in America.
Research reveals non-coding RNA in tumors may predict immunotherapy response and influence patients' outcomes. Specific repetitive elements were found to alter immune responses in colon and pancreatic cancers.
The Collaborative for Healing and Renewal in Medicine has presented a framework for individuals, organizations, and health systems to address physician burnout. The Charter on Physician Well-Being provides guidelines for developing regulations and policies that support physician well-being and maximize meaningful engagement.
A study by Mount Sinai researchers found associations between age, body mass index, substance use, and brain structure in patients with psychosis. Higher IQs were positively linked to improved brain health, while higher age, BMI, and substance use were negatively associated.
A newly identified protein, RGSz1, can be manipulated to make opioid painkillers effective at lower doses while reducing the risk of addiction. This discovery provides novel avenues for pharmacological interventions that can optimize the actions of opioid medications and lead to safer treatments.
Grape-derived polyphenols, such as DHCA and Mal-gluc, may attenuate depression by targeting inflammation and synaptic plasticity. The study found that these compounds can promote resilience in mouse models of depression by modulating immune responses and brain function.
Researchers found that adding cetirizine to standard therapy significantly reduced annualized relapse rates in patients with neuromyelitis optica, a rare disease causing inflammation and demyelination. The study suggests that cetirizine may be beneficial in preventing relapses by modulating eosinophil activity.
A Mount Sinai study found that white adults with mental illness were 50% more likely than blacks to experience delays in care, and 20% more likely to lack sufficient funds for treatments. The researchers suggest that the Great Recession may have contributed to these disparities.
Researchers trained machine learning models on radiologist reports to identify clinical concepts in CT scans, achieving an accuracy of 91%. This technology will help develop artificial intelligence to diagnose diseases and improve patient care.
A new study found that direct aspiration first pass (ADAPT) approach is clinically equivalent to stent retriever first-line (SRFL) approach for treating large vessel occlusion strokes. Patients treated with ADAPT achieved functional independence at 90 days similar to those treated with SRFL.
A computer-based language classifier predicted psychosis in at-risk youths with up to 83% accuracy, identifying disturbances in speech flow and tangential thinking as indicative of psychosis. The technology has the potential to improve prediction and prevention of psychosis by targeting cognitive deficits.